MNKD News 7.34 08/27/2014 05:25:01 Mannkind Corp (MNKD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mannkind Corp (MNKD) 7.34 $MNKD

MNKD, DEPO, RWR, NTES, TTM, PAY Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Aug 18, 7:20AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Mannkind Corp (NASDAQ:MNKD), Depomed Inc (NASDAQ EPO), Dj Wilshire Reit Etf (NYSE:RWR), NetEase.com Inc (NASDAQ:NTES), Tata Motors Ltd (NYSE:TTM), VeriFone Systems Inc (NYSE AY) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Ebola Vaccine and Inhaled Insulin Incoming
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat Aug 16, 5:01AM CDT
In this healthcare-focused of episode of Where The Money Is, analysts David Williamson and Michael Douglass tackle the weeks biggest stories in pharma and biotech, and how the industry is attempting to combat the Ebola Outbreak. MannKind's big news...

MannKind Falls 2.70% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Aug 15, 4:32PM CDT
MannKind (NASDAQ:MNKD) traded in a range yesterday that spanned from a low of $6.66 to a high of $7.11. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $7.00 on volume of 16.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna
PR Newswire - Thu Aug 14, 7:30AM CDT
Today, Analysts Review released its research reports regarding Tekmira Pharmaceuticals Corp. (NASDAQ: TKMR), MannKind Corp. (NASDAQ: MNKD), Eli Lilly and Company (NYSE: LLY), GlaxoSmithKline PLC (NYSE: GSK) and Cigna Corp. (NYSE: CI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5727-100free.

5 Things MannKind Corp.'s Management Wants You to Know
Brian Orelli, The Motley Fool - Motley Fool - Wed Aug 13, 5:30PM CDT
MannKind recently signed a marketing partnership with Sanofi and later in the day held a second conference call to discuss its second-quarter earnings. Here are five quotes from MannKind's management with details on the future of the company and...

Blame MannKind's Fall on its Bloated Balance Sheet
at The Street - Wed Aug 13, 11:04AM CDT
Even in biotech where the "blue sky" potential for experimental drugs so often sends stock prices soaring, no company can escape the gravitational pull of balance sheets and income statements.

Uptrend Call Working As MannKind Stock Rises 0.6% (MNKD)
Comtex SmarTrend(R) - Tue Aug 12, 11:11AM CDT
SmarTrend identified an Uptrend for MannKind (NASDAQ:MNKD) on April 2nd, 2014 at $7.46. In approximately 4 months, MannKind has returned 0.60% as of today's recent price of $7.50.

MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 10:05AM CDT
MannKind's (MNKD) loss of 19 cents per share was wider than the Zacks Consensus Estimate of a loss of 11 cents

eResearch Highlights NASDAQ Volume Leaders for Monday, August 11
ACCESSWIRE - Tue Aug 12, 9:02AM CDT
TORONTO, ON / ACCESSWIRE / August 12, 2014 / eResearch Corporation collaborates with theUpTrend.com in providing technical charts and opinions on the previous day's largest share volume leaders for each of the three major North American stock exchanges (on a rotating daily basis).

Critical Alerts For MannKind, Kinder Morgan, Kohls, Maxim Integrated Products and United Technologies. Released By InvestorsObserver
PR Newswire - Tue Aug 12, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for MNKD, KMI, KSS, MXIM and UTX.

MannKind Corporation Stock Signs Up Sanofi, Investors Conflicted
Brian Orelli, The Motley Fool - Motley Fool - Tue Aug 12, 6:00AM CDT
After years of discussions, MannKind finally has a partner for its inhaled insulin Afrezza. And a pretty good one at that. Source: MannKind The biotech announced a deal with diabetes expert Sanofi yesterday. There are two ways of...

MannKind Enters into a Global Deal with Sanofi for Afrezza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 11, 4:20PM CDT
MannKind (MNKD) has a inked a deal with Sanofi (SNY) on Afrezza.

Look for Shares of MannKind to Potentially Pullback after Yesterday's 4.92% Rise
Comtex SmarTrend(R) - Mon Aug 11, 3:50PM CDT
MannKind (NASDAQ:MNKD) traded in a range yesterday that spanned from a low of $8.31 to a high of $10.08. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $8.30 on volume of 62.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

4 Big Stocks to Trade (or Not)
at The Street - Mon Aug 11, 2:13PM CDT
Here's a look at how to trade some of the most active stocks on the market today.

Sanofi partners with MannKind for Afrezza (insulin human) Rapid-Acting Inhaled Insulin
M2 - Mon Aug 11, 11:06AM CDT
Therapeutic solution company Sanofi (EURONEXT:SAN)(NYSE:SNY) on Monday reported a worldwide exclusive licensing agreement for development and commercialisation of Afrezza (insulin human) Inhalation Powder in partnership with MannKind (NasdaqGM:MNKD).

Jim Cramer's Mad Dash: Good News for Tesla and MannKind
at The Street - Mon Aug 11, 10:48AM CDT
TheStreet's Jim Cramer takes a look at what's pushing shares of Tesla Motors and MannKind higher on Monday.

Stocks Higher, Nasdaq Leads; Kinder Morgan, Priceline Rising
at Investor's Business Daily - Mon Aug 11, 9:31AM CDT
A rally in global markets and positive investor reaction to one of the energy industry's largest proposed merger deals helped send stocks higher early Monday. The Nasdaq jumped 0.6%, led by Tesla Motor's (TSLA) 5% gain. The S&P 500 climbed 0.5% and...

MannKind Corporation Reports 2014 Second Quarter Financial Results
GlobeNewswire - Mon Aug 11, 8:59AM CDT
MannKind Corporation (Nasdaq:MNKD) today reported financial results for the second quarter ended June 30, 2014.

Why ManKind (MNKD) Stock Is Soaring Today
at The Street - Mon Aug 11, 7:20AM CDT
Sanofi (SNY) agreed to pay the biopharmaceutical company up to $925 million for global rights to the world’s only available inhaled insulin.

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin
PR Newswire - Mon Aug 11, 6:00AM CDT
Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (Nasdaq: MNKD) announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza® (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. The companies plan to launch Afrezza in the United States in the first quarter of 2015.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 87

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 26

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 183

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 123

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 54

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
RayNeo's Black Friday Push Tests Smart Glasses Demand

Updated Category News Views 85

A million shipped pairs is a real milestone, but holiday markdowns are where the rubber meets the road for RayNeo. The company is taking its XR gaming glasses and iO AI smart glasses into Europe’s Black Friday scrum with discounts running through late November, betting that portability, giant virtual screens and a little AI convenience can pry open consumers’ wallets....

Continue Reading
Trinity's Minneapolis Move Signals Freight Momentum

Updated Category News Views 54

A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...

Continue Reading
LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 31

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 68

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 229

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading

Top 5 Most Recently Viewed Articles

Desreta Jackson's New Show: A Journey of Healing and Legacy

Updated Category News Views 551

Desreta Jackson Unveils Groundbreaking Show This Fall Desreta Jackson, who captivated audiences through her memorable role as young Celie in Steven Spielberg's acclaimed film The Color Purple, is set to make her return to the limelight with the launch of The Desreta Jackson Show this fall. Produced by Desicon Pictures, the show seeks to ignite meaningful conversations...

Continue Reading
Clarios Unveils Ambitious Initiative to Transform U.S. Manufacturing

Updated Category News Views 354

Clarios Set to Revolutionize U.S. Manufacturing Landscape Clarios is embarking on an exciting journey to bolster American manufacturing, with plans to establish a cutting-edge technology campus focusing on advanced supercapacitor systems production. This initiative is part of a comprehensive $6 billion investment strategy aimed at strengthening domestic supply chains....

Continue Reading
Franchise Equity Partners Expands with Strategic Valvoline Deal

Updated Category News Views 274

Franchise Equity Partners Forms Strategic Partnership with Valvoline Franchise Equity Partners (FEP) is thrilled to announce a new strategic partnership with Valvoline Inc. This collaboration marks a significant milestone as FEP plans to acquire 38 Valvoline company-owned stores. The stores, located in various regions of Texas, will be transitioning to a newly established...

Continue Reading
New Found Gold Announces Successful Financing Round Closing

Updated Category News Views 183

Recent Financing Success of New Found Gold New Found Gold Corp. (TSXV: NFG) (NYSE-A: NFGC) is excited to share the successful closing of its second and final tranche in the bought deal financing, securing a remarkable C$63 million to advance its projects. This milestone marks a significant achievement for the Company, facilitating crucial developments in the exploration...

Continue Reading
Joby Aviation Surpasses Expectations in Q3 Financials

Updated Category News Views 194

Joby Aviation's Remarkable Growth in Q3 Joby Aviation, Inc. (NYSE: JOBY) has recently experienced a substantial surge in stock value, reflecting investor confidence following the release of its third-quarter earnings report. This report highlighted significant movements, particularly as it beat estimates on revenue, even though it faced a mixed assessment regarding its...

Continue Reading